BioCentury | May 31, 2010
Finance

Performance Counts

...that time, the company created its U.S. base via a reverse merger onto NASDAQ with CancerVax Corp....
BioCentury | Jun 4, 2007
Strategy

Rearview mirror

...hold out for a reverse merger with a company "with more cash and analyst coverage." "CancerVax...
...best move." Micromet AG , another European transplant from Germany, did a reverse merger into CancerVax Corp....
BioCentury | May 7, 2007
Finance

Global visibility

...Solexa have raised money using a committed equity financing facility (CEFF). MITI, which reversed into CancerVax Corp....
BioCentury | Mar 19, 2007
Company News

Micromet, Tracon deal

...million in upfront and milestone payments, plus royalties. MITI gained D93 in its merger with CancerVax Corp....
BioCentury | Mar 19, 2007
Finance

Ebb & Flow

...the recombinant humanized IgG1 MAb, which MITI gained in its reverse merger last year with CancerVax...
BioCentury | Mar 17, 2007
Company News

Micromet, Tracon cancer deal

...growth and metastasis by targeting cleaved collagen . MITI gained D93 in its reverse-merger with CancerVax...
BioCentury | Jan 1, 2007
Company News

Receptor BioLogix management update

...at Threshold Pharmaceuticals Inc. ; Guy Gammon as CMO, formerly VP of clinical development at CancerVax Corp....
BioCentury | Oct 9, 2006
Finance

Ebb & Flow

...Technology by AZN; and the merger of Micromet (now MITI) from the unquoted portfolio with CancerVax...
BioCentury | Oct 9, 2006
Company News

Curis, Micromet cancer, neurology, dermatology news

...see BioCentury, July 9, 2001). The companies had been disputing whether MITI's May merger with CancerVax Corp....
BioCentury | Sep 25, 2006
Strategy

Midcap wake-up call

...achieve critical mass in oncology through in-licensing deals with Micromet Inc. (MITI, Carlsbad, Calif.) and CancerVax Corp....
...cancer and breast cancer. But SEO's bet on cancer vaccines did not pay off, as CancerVax's...
Items per page:
1 - 10 of 160
BioCentury | May 31, 2010
Finance

Performance Counts

...that time, the company created its U.S. base via a reverse merger onto NASDAQ with CancerVax Corp....
BioCentury | Jun 4, 2007
Strategy

Rearview mirror

...hold out for a reverse merger with a company "with more cash and analyst coverage." "CancerVax...
...best move." Micromet AG , another European transplant from Germany, did a reverse merger into CancerVax Corp....
BioCentury | May 7, 2007
Finance

Global visibility

...Solexa have raised money using a committed equity financing facility (CEFF). MITI, which reversed into CancerVax Corp....
BioCentury | Mar 19, 2007
Company News

Micromet, Tracon deal

...million in upfront and milestone payments, plus royalties. MITI gained D93 in its merger with CancerVax Corp....
BioCentury | Mar 19, 2007
Finance

Ebb & Flow

...the recombinant humanized IgG1 MAb, which MITI gained in its reverse merger last year with CancerVax...
BioCentury | Mar 17, 2007
Company News

Micromet, Tracon cancer deal

...growth and metastasis by targeting cleaved collagen . MITI gained D93 in its reverse-merger with CancerVax...
BioCentury | Jan 1, 2007
Company News

Receptor BioLogix management update

...at Threshold Pharmaceuticals Inc. ; Guy Gammon as CMO, formerly VP of clinical development at CancerVax Corp....
BioCentury | Oct 9, 2006
Finance

Ebb & Flow

...Technology by AZN; and the merger of Micromet (now MITI) from the unquoted portfolio with CancerVax...
BioCentury | Oct 9, 2006
Company News

Curis, Micromet cancer, neurology, dermatology news

...see BioCentury, July 9, 2001). The companies had been disputing whether MITI's May merger with CancerVax Corp....
BioCentury | Sep 25, 2006
Strategy

Midcap wake-up call

...achieve critical mass in oncology through in-licensing deals with Micromet Inc. (MITI, Carlsbad, Calif.) and CancerVax Corp....
...cancer and breast cancer. But SEO's bet on cancer vaccines did not pay off, as CancerVax's...
Items per page:
1 - 10 of 160